Showing results (271-280 of 292) with videos related to

Sort By:
Pageof 30
JAMA|February 18, 1998
Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukastM E Wechsler, E Garpestad, S R Flier, et al.
American Journal of Respiratory and Critical Care Medicine|June 25, 1998
Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitisE K Silverman, H A Chapman, J M Drazen, et al.
American Journal of Respiratory and Critical Care Medicine|December 9, 2000
Gender-related differences in severe, early-onset chronic obstructive pulmonary diseaseE K Silverman, S T Weiss, J M Drazen, et al.
The New England Journal of Medicine|September 19, 1996
Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research NetworkJ M Drazen, E Israel, H A Boushey, et al.
American Journal of Respiratory and Critical Care Medicine|March 20, 2001
The transcription factor early growth-response factor 1 modulates tumor necrosis factor-alpha, immunoglobulin E, and airway responsiveness in miceE S Silverman, G T De Sanctis, J Boyce, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 23, 2004
[Registration of clinical trials: a statement from the International Committee of Medical Journal Editors]C DeAngelis, J M Drazen, F A Frizelle, et al.
The European Respiratory Journal|January 2, 2008
Global strategy for asthma management and prevention: GINA executive summaryE D Bateman, S S Hurd, P J Barnes, et al.
The Journal of Experimental Medicine|May 20, 1999
Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthmaG T De Sanctis, J A MacLean, K Hamada, et al.
The American Journal of Physiology|June 1, 1996
Production and characterization of guinea pig IL-5 in baculovirus-infected insect cellsM Mansour, M Karmilowicz, S J Hawrylik, et al.
Frontiers in Allergy|December 27, 2024
European biologic training course for type 2 inflammation by EUFOREA in 2024: key facts and lessons learnedD M Conti, V Backer, W Fokkens, et al.
Pageof 30